glycerylphosphorylcholine has been researched along with Brain Vascular Disorders in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amenta, F; Tayebati, SK; Tomassoni, D | 1 |
| Artemova, IIu; Boĭko, AN; Ganzhula, PA; Ismailov, AM; Khozova, AA; Kostenko, EV; Lisenker, LN; Otcheskaia, OV; Petrov, SV; Petrova, LV; Rotor, LD; Vdovichenko, TV | 1 |
| Amenta, F; Carotenuto, A; Fasanaro, AM; Rea, R; Traini, E | 1 |
| Amenta, F; Avola, R; Mignini, F; Parnetti, L; Tomassoni, D | 1 |
| Amenta, F; Gallai, V; Parnetti, L | 1 |
2 trial(s) available for glycerylphosphorylcholine and Brain Vascular Disorders
| Article | Year |
|---|---|
[The use of cerepro (choline alfoscerate) in the treatment of outpatients with chronic progressive cerebrovascular disease].
Topics: Aged; Aged, 80 and over; Ambulatory Care; Cerebrovascular Disorders; Chronic Disease; Drug Therapy, Combination; Female; Glycerylphosphorylcholine; Humans; Male; Middle Aged; Treatment Outcome | 2012 |
The ASCOMALVA trial: association between the cholinesterase inhibitor donepezil and the cholinergic precursor choline alphoscerate in Alzheimer's disease with cerebrovascular injury: interim results.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cerebrovascular Disorders; Donepezil; Double-Blind Method; Female; Follow-Up Studies; Glycerylphosphorylcholine; Humans; Indans; Male; Mental Status Schedule; Middle Aged; Nootropic Agents; Piperidines; Treatment Outcome | 2012 |
3 other study(ies) available for glycerylphosphorylcholine and Brain Vascular Disorders
| Article | Year |
|---|---|
Cerebrovascular and blood-brain barrier morphology in spontaneously hypertensive rats: effect of treatment with choline alphoscerate.
Topics: Animals; Aquaporin 4; Blood Pressure; Blood-Brain Barrier; Body Weight; Brain; Cerebrovascular Disorders; Claudin-5; Disease Models, Animal; Glial Fibrillary Acidic Protein; Glycerylphosphorylcholine; Hypertension; Male; Neuroprotective Agents; Organ Size; P-Selectin; Platelet Endothelial Cell Adhesion Molecule-1; Rats, Inbred SHR; Rats, Inbred WKY | 2015 |
Effect of treatment with choline alphoscerate on hippocampus microanatomy and glial reaction in spontaneously hypertensive rats.
Topics: Analysis of Variance; Animals; Blotting, Western; Cell Count; Cerebrovascular Disorders; Disease Models, Animal; Drug Administration Schedule; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Glycerylphosphorylcholine; Hippocampus; Immunohistochemistry; Male; Neuroglia; Phosphatidylcholines; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 2006 |
Choline alphoscerate in cognitive decline and in acute cerebrovascular disease: an analysis of published clinical data.
Topics: Cerebrovascular Disorders; Clinical Trials as Topic; Cognition Disorders; Dementia, Vascular; Glycerylphosphorylcholine; Humans; Parasympathomimetics; Periodicals as Topic; Statistics as Topic | 2001 |